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Introduction
Anatomical and functional differences between fetal
and mature immune system explain their various reac-
tivity [1]. Since the fetal Th1/Th2 cell balance is toward
Th2 cells, the immune system synthesizes mainly Th2
cytokines, i.e., IL-4, IL-5, IL-9, IL-10, and TGF-β [2-4].
Moreover, the production of pro-inflammatory mole-
cules is decreased. Such adaptive mechanisms are
responsible for the tolerance between maternal organ-
ism and feto-placental complex, which could be
regarded as a semi-allogeneic graft due to high level of
paternal antigens [2-5]. In contrast, Th1/Th2 imbalance
could increase Th1 cytokines synthesis (i.e., IFN-γ,
TNF, IL-1, IL-2, IL-6) that may convert macrophages
and NK cells into lectin-activated killers (LAK). The
process is highly accelerated due to catalytic capacity
of LAKs. Simultaneously, reduction of orexin-2 (OX-2)
and increase of pro-thrombinase (fgl2) synthesis by
trophoblastic cells occurs. Fgl2 inhibits OX-2 expres-
sion itself and converts pro-thrombin into thrombin
that activates IL-8 synthesis by endothelial cells and
stimulates neutrophils. Both processes are responsible
for a vascular thrombosis and assault of the feto-palcen-
tal complex, respectively [3,4]. In such situation, the
prolonged placental blood flow termination leads to
embryo/fetal malnutrition that could manifest as
intrauterine growth retardation (IUGR), developmental
abnormalities or even embryo/fetal dead. All those bio-
chemical and immunological anomalies may be influ-
enced by various infectious, physical and psychological
agents, as well as toxicants, including drugs [6].
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Abstract: Unusual expression of interleukin-1alpha, -1beta and -6 was previously found in the epiphyseal cartilage of rat
fetuses prenatally exposed to various non-steroidal anti-inflammatory drugs (NSAID, i.e., ibuprofen, piroxicam, tolmetin)
and selective cyclooxygenase-2 inhibitor (DFU). The aim of the present study was to evaluate the role of placenta in such
phenomenon. Morphology of the organ, thickness of basal and labyrinth layer, immunoexpression of COX isoenzymes were
examined, and confronted with maternal biochemical data and fetal developmental parameters. Higher maternal urea level,
as well as lower placental weight and labyrinth thickness were found in the group of fetuses who revealed expression of
genes coded the selected interleukins, when compared with the xenobiotic-exposed pups without the selected genes expres-
sion and untreated control. A significant correlation between placental weight and maternal total protein or urea level was
revealed. Histological changes like inflammatory infiltration and calcification were observed sporadically. Location and
intensity of COX-1 staining was similar in all cases. However, more intense COX-2 staining for majority of cells of the basal
zone and in dispersed giant cells of the labyrinth was found in inflamed organs. It could be concluded that abnormal expres-
sion of the selected interleukins is associated with low placental weight and decrease of its thickness, especially labyrinth
zone, as well as with high maternal urea level.
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An unexpected expression of genes coded IL-1α,
IL-1β and IL-6 was revealed in epiphyseal cartilages
in a few rats fetuses in-utero treated with various non-
selective (ibuprofen, piroxicam, tolmetin) and selec-
tive (DFU*) cyclooxygenase-2 (COX-2) inhibitors [7].
Interestingly, the expression was found only in drug-
treated groups, mostly exposed to low and middle
doses, which were well-tolerated by both dams and
fetuses (Table 1). It seems that due to immaturity of
fetal immune system the only source of those
cytokines could be the placenta or maternal circula-
tion, and cytokines could cross the impaired placental
barrier [2-4,8]. The present study was undertaken to
evaluate the role of placenta in such phenomenon. 
Materials and methods
Animals and study protocol. The applied methodology was sim-
ilar to other developmental toxicological studies and was described
in details elsewhere [7,9-12]. Succinctly, 280 (20/group) time-
pregnant Wistar CRL:(WI)WUBR rats were intragastrically treat-
ed on gestational day (GD) 8-21 with various COX inhibitors.
Ibuprofen (8.5, 85.0 and 400.0 mg/kg/dose) and tolmetin (8.5, 85.0
and 850.0 mg/kg/dose) were administered three-times a day, while
DFU (0.2, 2.0 and 20.0 mg/kg/dose) and piroxicam (0.3, 3.0 and
30.0 mg/kg/dose) were given once daily. Animals in control groups
received the Tween 80 water suspension in volume corresponding
to those given (10 ml/kg) in drug-treated groups (Table 1). On GD
21 dames were sacrificed, their blood was collected, and abdomi-
nal organs were delivered. The maternal blood was centrifuged and
alanine and aspartate aminotransferase activity, as well as urea and
total protein level were determined in the sera. Ovarian corpora
lutea, resorption sites, dead or live fetuses were counted. Fetuses
were removed from uterus, separated from placenta, and routinely
teratologically examined [9]. The weight of fetuses and placentas,
and the fetal crown-rump length were checked. Skeletal and inter-
nal organ morphology, as well as various histological, immunohis-
tochemical [7] and radiological [12] fetal examinations were also
performed.
One well-developed, randomly chosen male fetus and its
adjusted placenta was taken from 10 randomly selected litters of
each experimental group. However, due to maternal mortality, the
final number of evaluated litters in groups exposed to the highest
doses of tolmetin and ibuprofen was only 4 and 6, respectively. 
Gene expression. The proximal and distal femoral fetal epiphyses
were separated and their RNA was extracted. The expression of
genes coded collagen type I and X, COX-1, COX-2, IL-1α, IL-1β,
IL-6, osteopontin, osteocalcin, TNF-α, TNF-β, L32 and GAPDH
was checked using RNase Protection Assay (RPA) with custom
multi probe template sets (PharMingen Laboratory; San Diego CA,
USA) according to manufacturer directions. The level of mRNA
was estimated using computer software TotalLab (BioSystematica,
UK), in reference to the mRNA level of the house keeping gene –
L32 [7].
Immunohistochemistry. All the selected placentas were cut trans-
versally on the level of the umbilical cord adjustment, fixed in 10%
buffered formalin, embedded in paraffin blocks, sectioned at 5 μm
and routinely stained with hematoxylin and eosin (H+E). Immuno-
histochemical reactions for both COX isoforms were performed
on the 4 μm slides obtained from the paraffin blocks previously
used for histological examination. Monoclonal mouse anti-
human antibodies against COX-1 and COX-2 (clones 12E12 and
4H12, respectively; Novocastra; Newcastle, UK) and DakoEnvi-
sion+TM/HRP kit (DakoCytomation, Glostrup, Denmark) were
applied. The details of the method were described elsewhere [13].
Slides were evaluated without knowledge of the treatment
groups, using light microscope (Olympus BX45; Tokyo, Japan).
The thickness of the basal (junctional) zone and the labyrinth of
the placenta was measured using the eyepiece micrometer at the
objective 10x (Fig. 1). The obtained results were expressed as
absolute (in millimeters) and relative values (vs. the whole pla-
cental thickness).
Ethical issues. All the evaluated samples and data were collected
during the previous study that was designed in accordance with
international guidelines for teratological studies [9] and fully
approved by the Local Bioethical Committee (#372/2002).
Statistical analysis. Unlike typical teratological studies, the unit
for statistical measurement was the pregnant female, placenta or
single, male fetus selected for the genetic and histological evalua-
tion [9]. Homogeneity of distribution was examined using Kol-
mogorov-Smirnov test. Differences of normal distribution data
were analysed by ANOVA and followed by Duncan test. Inhomo-
geneous distribution data was analysed by Mann-Whitney U test.
The nominal scale measures were analyzed by Chi-square test with
Yates' correction for independent differences among experimental
groups. Spearman rank test was employed to evaluate correlations
between various factors. The 0.05 level (p<0.05) of probability was
used as the criterion of significance. Data were analyzed using
STATISTICA 5.0 on IBM compatible computer.
31Fetal cartilage IL expression and placental morphology
©Polish Histochemical et Cytochemical Society
Folia Histochem Cytobiol. 2010:48(1): 31 (30-36) 
10.2478/v10042-008-0097-1
* 5,5-dimethyl-3-(3-fluorophenyl)-4-(4-methylsulphonyl)phenyl-2(5H)-furanone
Table 1. Characteristic of litters/fetuses selected to the current
study
aC and Cx groups were pulled into one common control group due to lack
of statistical differences in both maternal and fetal parameters
Results
For the final statistical analysis data from 130 dams,
corresponding fetuses and placentas (including 20
from control groups) was taken.
The urea level was significantly lower in both drug-
exposed groups when compare with the control group
(Table 2). However, it was higher in the group of dams
whose pups exhibited expression of interleukins in the
epiphyseal homogenates. Lack of statistical differ-
ences was found for other biochemical parameters, as
well as both fetal developmental parameters, i.e., the
fetal weight and the crown-rump length. Placental
weight was significantly lower in the group of fetuses
who revealed expression of genes coded selected inter-
leukins in cartilages then in other two groups (Table 2).
In the group with expression of interleukin genes
most of the fetuses were obtained from mothers with
higher serum urea level, as well as with low placental
weight and thickness of the labyrinth (Table 3). When
maternal and feto-placental parameters were simulta-
neously evaluated, in the group without interleukin
genes expression a statistically significant correlation
between placental weight and urea or total protein
level was revealed (Fig. 2).
The evaluated placentas showed morphology typi-
cal of hemochorial – chorioallantoic ones, with well
developed basal zone and labyrinth. The basal zone
contained three main types of cells, i.e., undifferentiat-
ed, glycogen and giant trophoblasts cells, as well as
maternal vascular channels. Whereas labyrinth was
composed of dense network of lacunas filled with
maternal blood formed by the septa consisted of three
layers of trophoblasts and vascular fetal mesenchyma
(Fig. 1, 3). In majority of cases mild inflammatory
infiltration composed of neutrophils and degenerat-
ed/necrotic cells were found in the decidua basalis and
nearby basal zone of the placenta. However, in all pla-
32 F. Burdan et al.
©Polish Histochemical et Cytochemical Society
Folia Histochem Cytobiol. 2010:48(1): 32 (30-36) 
10.2478/v10042-008-0097-1
Table 2. Selected maternal, fetal and placental parameters in the control and drug-exposed groups according to ILs expression
*p<0.05 vs. control; #p<0.05 vs. IL absence
Table 3. The fetal incidence in corresponding to normala (95CI) and abnormal (<95 and >95CI) value of selected maternal and placental
parameters in drug-exposed groups according to ILs expression.
athe normal value was calculated as 95CI in the common control group
centas from group exposed to the highest dose of tol-
metin, six from group treated with middle dose of
piroxicam, four from control and one from group
received middle dose of DFU, the infiltration was
severe and observed both on the fetal aspect of the pla-
centa and deeply within both zones of the organ (Fig.
3A). Small foci of calcification were noted in the
maternal-fetal interface in three pups exposed to mid-
dle dose of piroxicam (2) and highest dose of tolmetin
(1) (Fig. 3B).
Unlike unaffected thickness of the basal zone, the
transversal diameter of the whole placenta and the
labyrinth was significantly lower in the group of rats
with expression of genes coded selected interleukins
(Table 2). 
The distribution and intensity of imunostaining for
COX-1 in placentas was similar in all groups. Except
for erythrocytes, strong cytoplasmic reaction was seen
in virtually all cells (Fig. 4A, B). Immunostaining for
COX-2 was usually very weak and confined mostly to
trophoblasts cells (layer 1) and endothelial cells of the
labyrinth (Fig. 4C). However in placentas infiltrated
by neutrophils, a strong nuclear staining was also
revealed in majority of cells of the basal zone and in
dispersed giant cells of the labyrinth (Fig. 4D).
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Fig. 1. The transversal section of the rat placenta; BZ – basal zone,
L – labyrinth (piroxicam 3.0 mg/kg/d H+E; bar – 1 mm).
Fig. 2. Correlation between placental weight and maternal urea (A) or total protein (B) level in rat fetuses prenatally exposed to cyclooxy-
genase inhibitors without expression of IL-1α, IL-1β and IL-6. Rs – Spearman rank R.
Fig. 3. Neutrophils on the fetal aspect of the placenta (A) and calcification in the basal zone of the placenta (B) (H+E; A – DFU 2 mg/kg/d,
objective 10×; B – tolmetin 2550 mg/kg/d, objective 20×).
Discussion
The obtained results indicated that unusual expression of
IL-1α, IL-1β and IL-6 was seen in fetuses delivered by
mothers with an abnormal urea level. The group was also
characterized by a low placental weight and thinner
labyrinth. Histological abnormalities, mostly dense
inflammatory infiltration and/or sparse foci of calcifica-
tions were revealed occasionally in all three evaluated
groups, including common control one. However, in ani-
mals exposed to the highest dose of tolmetin, placental
changes were found in all the examined litters. On the
other hand, placental histological abnormalities were
revealed only in four out of 10 organs obtained from
fetuses with a positive interleukins expression, as well as
in 12/100 organs of pups without genetic abnormalities
and exposed to the examined COX inhibitors. A lower
frequency (4/20) was found in the common control
group. Nevertheless, it has to be stated that mild inflam-
mation and focal necrosis of placenta are physiological
findings that could be observed also in healthy organs
from GD 17 until partum [14]. Lack of any serious
abnormalities typical for well-known placental toxicants,
like methyl parathion was found [15]. The inflammatory
process explains the strong immunoexpression of the
inducible COX isoform [16,17], while more intensive
staining for both, COX-1 and COX-2 of the basal zone
in the late gestation is physiological [18].
Interestingly, the previous results suggested that
among the whole group of animals exposed in-utero to
COX inhibitors, the abnormal urea and/or total protein
level was associated with increase incident of postim-
plantation loss and IUGR, low placental weight,
increase of skeletal developmental malformations and
variations [19], as well as decrease of vertebrae miner-
alization [12]. Such data was also partially proved for
domestic animals fed with diet rich with degradable
proteins that generate a high level of urea in maternal
blood [20,21]. However, a maternal toxicity can not be
taken into consideration as a leading mechanism that
explains interleukin expression, since the phenomenon
was observed mostly in fetuses obtained from mothers
without gross and histological signs of adverse effects
of the examined xenobiotics [10,11].
Although, damage of placental barrier was not proved
on histological level, such mechanism is the only one that
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Fig. 4. Immunohistochemical reaction for COX-1 (A, B) and COX-2 (C, D) in normal placenta (A, C) and infiltrated by neutrophils (B,
D) (A, C – ibuprofen 25.5 mg/kg/d; B, D – tolmetin 2550.0 mg/kg/d; DakoEnvisionTM+/HRP, objective 10x).
could explain positive IL-1α, IL-1β and IL-6 expression
in fetal cartilages. Since well-vascularised labyrinth was
the only affected part of the placenta, the mechanism may
be related to homodynamic changes in arteries that sup-
ply the organ. Due to high COX activity in endothelial
cells and thrombocytes, the examined drugs could affect
prostacyklin (PGI) and thromboxan (TXA2) synthesis,
respectively. Secondary to PGI/TXA2 modulation, the
local haemostatic changes occur, and temporary or per-
manent vascular occlusion could be generated [16,17,22].
The ischemia-reperfusion (I/R) injury itself is a pivotal
mechanism of IUGR and pre-eclampsia [22]. It could
also promote pathological changes that generate mater-
nal-fetal blood shunt [6,22]. Yamazaki et al. [23] report-
ed that I/R injury increase the placental COX-2 and EP3
receptor expression that may induce IUGR through the
prostaglandin E2 (PGE2) stimulation. However, accord-
ing to the authors the fetal effect was time-dependent
since significant changes in fetal weight were revealed
not earlier than 5 day after the uterinal artery was closed.
Furthermore, the thrombo-embolic episodes are well-
documented complications of some of the selective
COX-2 inhibitors therapy and were the main reason for
their withdrawn from the market. A new data suggests
that similar adverse effects could be observed in patients
taking nonselective compounds, as well [24,25]. It should
be also emphasized that COX inhibitors decrease synthe-
sis of PGE2, one of the strongest vasoconstrictor, which
stimulates mainly EP3 receptors [16,17]. Because there is
a dualistic influence of the examined drugs on
haemostase, other studies are needed to find the main
mechanism of placental injury. However, without mater-
nal blood and placental interleukin levels, as well as local
haemostatic examination such divagations are pure theo-
retical, since the cytokine source is unknown. An unusu-
al stimulation of the fetal immune system with secondary
activation of Th1 cytokines seems even less likely, espe-
cially since histological skeletal changes were observed
occasionally in the examined rat population [7]. On the
other hand, most of the currently studied fetuses showed
a positive expression of TNF [7], that is Th1 cytokine
promoting the immune response to infection [2,26,27].
Nevertheless, since TNF plays a cruciate role in various
processes such as organogenesis and initiation of partum
of the placenta [28], its expression in fetal tissues is phys-
iological through the mid and late pregnancy [27]. Its
concentration could be increased by various pathological
factors that also stimulate other Th1 cytokines, like IL-1
and -6, which may damage fetal and mature organs
[27,29-31]. Such mechanism was experimentally con-
firmed by Bell et al. [2]. The authors injected
lipopolysaccharide into the uterine cervix of pregnant rats
and found an increase of TNF concentration in the pla-
centa and the fetal brain, while the level of IL-1 was
increased only in the placenta and INF-γ exclusively in
the brain. Due to the fact that all those factors are respon-
sible for the neuronal degeneration [26,28], it is postulat-
ed that Th1 cytokines may induce congenital abnormali-
ties of the central nervous system. Since TNF and other
cytokines do not cross the healthy placenta [32], the
infected organ has to be the only source of the Th1
cytokines, especially TNF and IL-6. The role of intrauter-
ine infection in promotion of the brain congenital abnor-
malities has been already proved in experimental animal
models [33,34], but in none of the study placental mor-
phology was evaluated. However, Silen et al. [8] revealed
necrosis in both labyrinth and basal zones, as well as in
some organs of fetuses delivered by dams interperitonal-
ly injected with native IL-1α and TNF.
It should be also noted that low placental weight is
one of the most commonly affected developmental
parameter, observed in various teratological studies
[6,9]. Dose-dependent, however insignificant differ-
ences were revealed in groups treated with COX
inhibitors in the currently examined rat population
[10,11] and in some previous studies [6,9,35]. So-called
placental toxicity is a major factor explaining develop-
mental complications of arsenic, cadmium, chloroform,
enalapril, trypan blue and methyl parathion [6]. All the
compounds cause placental necrosis and enzymatic
changes that may compromise placental function.
Affecting gas exchange, nutrition uptake and abnormal
hormonal synthesis were also revealed during exposi-
tion to other chemicals, but none of the studies evaluat-
ed Th1 cytokines in the fetal tissues [3,6,9,15].
Lack of the differences in fetal weight and length
may be caused by the method used to select the pups for
genetic and histological examinations. Since only one
well-developed fetus from the litter without any signs of
external malformations and IUGR was evaluated, the
obtained results could be false negative and other studies
have to be taken to completely explain this phenomenon.
On the basis of obtained results, it could be conclud-
ed that abnormal expression of selected interleukins is
associated with low placental weight, decrease of pla-
cental thickness, particularly labyrinth, as well as with
high urea level in maternal blood. Other studies, espe-
cially multi-generation ones, are required to explain clin-
ical implications of this phenomenon [9,36,37]. An addi-
tional evaluation of specific placental hormones and pro-
teins [30,38] will be also desirable for the future human
risk assessment [9,30,36,37,39,40]. Histological placen-
tal examination seems to be important scientific proce-
dure, especially in cases the organ weight and fetal
abnormalities are revealed. Presently, according to inter-
national principles for developmental toxicological eval-
uations it is only an accessory facultative test [9].
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